“…At the same time, the extremely interesting properties possessed by those variants of consortia are created by cells of these prokaryotic microorganisms (i.e., bacteria and archaea) and eukaryotic microorganisms (in particular, filamentous fungi and yeast), which are able to coexist and catalyze biodegradation and bioremediation processes [ 12 ]. Such an artificial consortia, involving cells of microorganisms from different kingdoms [ 13 , 14 , 15 , 16 , 17 ], are especially attractive from a scientific and practical point of view, due to the possibility of expanding its total metabolic potential. At the same time, all the advantages that the artificial consortia of microorganisms themselves have over natural analogues, which have mainly been described in the literature on bacterial cells, are preserved: - easy-to-use reproducibility of the compositions of the consortia;
- the possibility of introducing maximum targeted metabolic activity into the consortia cells, which are improved, including through the genetic modification of cells;
- targeted variation of the ratios of cell concentrations in the consortium, to regulate the rates of associated biochemical processes catalyzed by cells;
- sustainable functioning of the created consortia, which are accompanied by increased degrees of conversion of the original substrates, including toxic compounds [ 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ].
…”